A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

HPV is a sexually transmitted infection (STI) that may not cause any symptoms in some people. However, certain strains of the virus can put certain individuals at a higher risk of developing cervical ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

The American College of Obstetricians and Gynecologists has updated its cervical cancer screening guidance to include patient-collected high-risk HPV testing for average-risk adults aged 30–65. This ...

Research has increasingly shown that HPV testing is more effective than cytology at detecting cervical precancer. A cohort study showed that patients who tested HPV negative had the lowest cumulative ...

The American Cancer Society is endorsing the use of self-swab kits to test for HPV, because they may reduce barriers to cervical cancer screening. The amended guidelines will "help improve compliance ...

Doctors say HPV is common, but vaccination and screening can prevent most cervical cancers.

The FDA has approved two new self-screening tests for HPV. Patients would be able to access the self-screening test at a physician’s office. While these tests can act as a supplement, the pelvic exam ...

Testing period blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for a smear test, researchers have said. Using a regular sanitary pad topped with a blood sample ...

Mel-Mont Medical, a women's health diagnostics company advancing accessible cervical cancer screening through HPV-positive patient risk assessment, announced today that it was recognized at the 2026 ...